1.A case with systemic disseminated fungal disease and reactive histiocytosis.
Chinese Journal of Pediatrics 2004;42(5):397-397
Antifungal Agents
;
therapeutic use
;
Fever
;
Histiocytosis
;
drug therapy
;
etiology
;
Humans
;
Infant
;
Lung Diseases, Fungal
;
complications
;
diagnosis
;
drug therapy
;
Male
2.Diagnosis and treatment of lung aspergillosis after liver transplantation.
Qi-yuan LIN ; Yong-heng ZHAO ; Lü-nan YAN ; An-hua HUANG ; Bo LI ; Shi-chun LU ; Yong ZENG ; Tian-fu WEN ; Ji-chun ZHAO ; Nan-sheng CHENG
Chinese Journal of Surgery 2003;41(1):17-18
OBJECTIVETo assess the diagnosis and treatment of invasive lung aspergillosis after liver transplantation.
METHODSRoutine sputum culture was performed. Itraconazole and fluconazole were used to prevent fungal infection prophylactically. Amphyotericin B was only used on aspergillosis. In 54 patients receiving, liver transplantation, 3 patients with lung aspergillosis were reviewed.
RESULTSOf the 3 patients 2 died and 1 recovered.
CONCLUSIONSOver-immunosuppression is a main risk factor for aspergillosis. Amphotericin B is still the best choice for the treatment of aspergillosis and its gradual, interrupted, low concentration administration, cooperated with itraconazole can ease the side effects.
Adult ; Aspergillosis ; diagnosis ; drug therapy ; etiology ; Female ; Humans ; Liver Transplantation ; adverse effects ; Lung Diseases, Fungal ; diagnosis ; drug therapy ; etiology ; Male ; Middle Aged
3.Aspergillus pneumonia in renal transplant recipients.
Xiao-dong ZHANG ; Xiao-peng HU ; Hang YIN ; Wei WANG ; Xin ZHANG ; Lin-Lin MA ; Yong WANG
Chinese Medical Journal 2008;121(9):791-794
BACKGROUNDFilamentous fungal infections are associated with a high morbidity and mortality in solid organ transplants. The present study aimed to investigate the aspergillus pneumonia in renal transplant recipients, and its diagnosis as well as treatment.
METHODSApproximately 2000 cases of renal transplants were retrospectively studied and we focused on cases hospitalized during August 1, 2005 and February 1, 2007, as the study period. The clinical database and electronic records were analyzed. Recently published literature was reviewed.
RESULTSThere was more diabetes and hypertension in the infected group than in the non-infected group (86% vs 62% and 57% vs 39%, respectively). Eighty-six percent of recipients from the infected group had delayed graft function. Seven cases with aspergillus pneumonia were identified based on either fungal culture or radiology. Of the 7 cases, 4 died in a few days after diagnosis. Liposomal amphotericin B was used as a first-line therapy.
CONCLUSIONSIncidences of fungal infection are increasing among renal transplant recipients. Early diagnosis and treatment are critical steps in curing aspergillosis.
Adult ; Aspergillosis ; diagnosis ; drug therapy ; etiology ; Cohort Studies ; Female ; Humans ; Kidney Transplantation ; adverse effects ; Lung Diseases, Fungal ; diagnosis ; drug therapy ; etiology ; Male ; Middle Aged ; Pneumonia ; diagnosis ; drug therapy ; etiology ; Retrospective Studies ; Tomography, X-Ray Computed
4.Diagnosis and treatment of invasive aspergillosis infection following orthotopic liver transplantation.
Shu-hong YI ; Gui-hua CHEN ; Min-qiang LU ; Yang YANG ; Chang-jie CAI ; Chi XU ; Hua LI ; Gen-shu WANG ; Hui-min YI
Chinese Journal of Surgery 2006;44(13):885-888
OBJECTIVETo explore the treatment and appropriate management of invasive aspergillosis infection following orthotopic liver transplantation.
METHODSThe clinical data of 576 cases who underwent orthotopic liver transplantation consecutively between January 2000 and January 2005 were analyzed retrospectively.
RESULTSThe prevalence of invasive aspergillosis infection was 1.74 (9/576), included 8 cases with pulmonary aspergillosis and 1 case with cerebral aspergillosis. The interval between transplantation and diagnosis were from 10 days to 2 months. Persistent or discontinuous low fever maybe the main clinical presentation after operation. Liposomal amphotericin B (AmBisome) is the mainly treatment for invasive aspergillosis infections, 5 patients were cured and 2 patients developed multi-organ aspergillosis infection died.
CONCLUSIONSThe clinical features of invasive aspergillosis infection following orthotopic liver transplantation were un-typical presentations in the early stage and easy to disseminate. Appropriate modification of immunosuppression therapy and early, high dose and long-term application of antifungal treatment is effective and safe to cure the disease.
Adult ; Aged ; Amphotericin B ; therapeutic use ; Antifungal Agents ; therapeutic use ; Aspergillosis ; diagnosis ; drug therapy ; etiology ; Female ; Humans ; Liver Transplantation ; adverse effects ; Lung Diseases, Fungal ; diagnosis ; drug therapy ; etiology ; Male ; Middle Aged ; Neuroaspergillosis ; diagnosis ; drug therapy ; etiology ; Postoperative Complications ; Retrospective Studies
5.Pulmonary fungal infection in malignant hematological diseases: an analysis of 14 cases.
Qi SHEN ; Xian-Min SONG ; Xiao-Ping XU ; Jian-Min WANG
Journal of Experimental Hematology 2005;13(6):1125-1127
The objective of this study was to evaluate the etiological factors, diagnosis and therapy of pulmonary fungal infection in hematological malignancies, 14 cases of malignant hematological disease with pulmonary fungal infection were collected and analyzed. The results showed that 11 out of 14 cases had the respiratory manifestations, sputum was sticky and difficult to be expectorated in 7 cases, X rays in chests showed shadows with features of stigma and sheet in 11 cases, Candida albicans and aspergillus infection were observed in 10 and 2 cases respectively, the numbers of neutrophil were below 0.5 x 10(9)/L in 8 cases and below 1.0 x 10(9)/L in 3 cases respectively, fluconazole was used for 12 cases and clinical symptoms of 11 cases were improved within two weeks. In conclusion, the occurrence of pulmonary fungal infection in malignant hematological diseases is associated with intensive chemotherapy, decrease of neutrophil counts and using of broad-spectrum antibiotics, the diagnosis at early stage is difficult and clinicians should pay more attention to its clinical and laboratory examinations, and give them therapy in time.
Adolescent
;
Adult
;
Aged
;
Antifungal Agents
;
therapeutic use
;
Aspergillosis
;
complications
;
diagnosis
;
drug therapy
;
Candidiasis
;
complications
;
diagnosis
;
drug therapy
;
Female
;
Fluconazole
;
therapeutic use
;
Hematologic Neoplasms
;
drug therapy
;
etiology
;
pathology
;
Humans
;
Lung Diseases, Fungal
;
complications
;
diagnosis
;
drug therapy
;
Male
;
Middle Aged
;
Treatment Outcome
6.Clinical features of invasive pulmonary fungal infection secondary to malignant blood diseases.
Xue-Feng SUN ; Bing HAN ; Jun FENG ; Dao-Bin ZHOU ; Shu-Jie WANG ; Ying XU ; Jia-Lin CHEN ; Li JIAO ; Wei ZHANG ; Jian LI ; Ming-Hui DUAN ; Tie-Nan ZHU ; Nong ZOU ; Bao-Lai HUA ; Hua-Cong CAI ; Yong-Qiang ZHAO
Acta Academiae Medicinae Sinicae 2009;31(5):575-579
OBJECTIVETo summarize the clinical features of invasive pulmonary fungal infection (IPFI) secondary to malignant blood diseases (MBD).
METHODSWe retrospectively analyzed the clinical data of 52 patients with IPFI secondary to MBD admitted to Peking Union Medical College Hospital from January 1995 to December 2008.
RESULTSThe incidences of IPFI secondary to acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), non-Hodgkin's lymphoma (NHL), and aplastic anemia (AA) were 4.6%, 3.2%, 2.8%, and 2.5%, respectively. In patients with IPFI secondary to AML, 88.5% (23/26) of the patients suffered from the infections during the non-remission (NR) period (including relapse), and 11.5% (3/26) in the complete-remission (CR) period. In all the patients with IPFI secondary to malignant blood diseases, 86.5% (45/52) of MBD were neutropenic or agranulocytic, and 67.3% (35/52) had been treated with broad-spectrum antibiotics for more than 96 hours before anti-fungal therapy. The total mortality after anti-fungal therapy was 13.7% (7/51). More than half of patients with fluconazole or itraconazole as the first-line therapy had to switch to other medicines because of poor infection control.
CONCLUSIONSIPFI secondary to MBD is most common in AML patients. Patients with NR of AML, neutropenia or agranulocytosis, and long-term broad-spectrum antibiotics usage are susceptible to IPFI. Fluconazole and itraconazole have low efficacy, and other more potent anti-fungal medicines should be considered.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Hematologic Neoplasms ; complications ; Humans ; Lung Diseases, Fungal ; diagnosis ; drug therapy ; etiology ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
7.A Case of Adult-Onset Still's Disease Complicated with Diffuse Alveolar Hemorrhage.
Ismail SARI ; Merih BIRLIK ; Omer BINICIER ; Servet AKAR ; Erkan YILMAZ ; Fatos ONEN ; Nurullah AKKOC
Journal of Korean Medical Science 2009;24(1):155-157
Adult-onset Still's disease (AOSD) is an inflammatory disease that presents with a variety of clinical symptoms. Pulmonary involvement is well-known in AOSD and is seen in up to 53% of AOSD cases, with the most common pulmonary diseases being pleural effusion and transient pulmonary infiltrates. We present the first case of chronic AOSD complicated with diffuse alveolar hemorrhage during the acute flare of the disease.
Adult
;
Ankylosis/diagnosis
;
Anti-Inflammatory Agents/administration & dosage
;
Diagnosis, Differential
;
Female
;
Fever of Unknown Origin/diagnosis
;
Hemorrhage/*diagnosis/drug therapy/etiology
;
Humans
;
Lung Diseases/*diagnosis/drug therapy/etiology
;
Methylprednisolone/administration & dosage
;
*Pulmonary Alveoli
;
Still's Disease, Adult-Onset/complications/*diagnosis/drug therapy/radiography
;
Tomography, X-Ray Computed
8.Case 136th--intermittent fever for over 20 days and coughing for 2 days.
Sainan SHU ; Sanqing XU ; Yaqin WANG ; Feng YE ; Hua ZHOU ; Feng FANG
Chinese Journal of Pediatrics 2014;52(1):72-74
Amphotericin B
;
administration & dosage
;
therapeutic use
;
Antifungal Agents
;
administration & dosage
;
therapeutic use
;
Biomarkers
;
blood
;
Child
;
Cough
;
diagnosis
;
drug therapy
;
etiology
;
Cryptococcosis
;
Fever
;
diagnosis
;
drug therapy
;
etiology
;
Fluconazole
;
administration & dosage
;
therapeutic use
;
Humans
;
Lung
;
diagnostic imaging
;
pathology
;
Lung Diseases, Fungal
;
complications
;
diagnosis
;
drug therapy
;
Male
;
Radiography, Thoracic
;
Tomography, X-Ray Computed
9.Clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease.
Li CHEN ; Yan HU ; Yuan YAO ; Xiao-fang ZHEN ; Fang CHEN ; Qiang HE ; Xin MO ; Song-Chun MA
Chinese Journal of Pediatrics 2012;50(6):465-469
OBJECTIVETo explore the clinical and laboratory features and the prognosis of juvenile dermatomyositis (JDM) complicated with interstitial lung disease (ILD).
METHODData of 39 cases of JDM complicated with ILD hospitalized in Beijing Children's Hospital from January 2005 to December 2011 were collected. The clinical features, laboratory data and prognosis of these children were analyzed.
RESULTOf the 39 cases studied, 16 were boys, and 23 girls. The average age of onset was 5.6 years, and 61.5% of the patients' age of onset (24 cases) was under 6 years. Rashes (17 cases, 43.6%), simultaneous eruption of rashes and muscle weakness (14 cases, 35.9%), fever (4 cases, 10.1%), or muscle weakness (3 cases, 7.7%) were common initial symptoms of the disease. Only 51.3% of the patients (20 cases) had the symptoms of respiratory system, but (24 cases) 61.5% were complicated with that of the gastrointestinal system; (27 cases) 69.2% had at the same time electrocardiographic and echocardiographic abnormalities. The chest high resolution computed tomography (HRCT) showed cord or band-like shadows in their lungs of more than half of the cases (25 cases, 64.1%), and other changes included ground glass-like shadow (10 cases, 25.6%), net and lineation-like shadow (9 cases, 23.1%), nodular change (5 cases, 12.8%). The patients complicated with lung essential infiltration accounted for as high as 71.8% (28 cases). These imaging changes were largely seen on both dorsal sides of their lungs. Severe patients also had mediastinal emphysema, pneumothorax, pneumorrhagia or aerodermectasia. Twenty-four patients underwent pulmonary function examination, and 62.5% of the patients' pulmonary function (15 cases) was abnormal. The fatality rate of the cases studied was 10.1%.
CONCLUSIONThe imaging changes of patients suffering from JDM with ILD were often more severe as compared to the clinical symptoms, and were often complicated with damages to other systems and organs. The prognosis of those patients was poorer than others. Patients with JDM especially at a younger age of onset and with various organ damages should be examined with chest HRCT examinations as early as possible.
Child ; Child, Preschool ; Dermatomyositis ; complications ; diagnosis ; drug therapy ; Female ; Glucocorticoids ; administration & dosage ; therapeutic use ; Humans ; Immunosuppressive Agents ; administration & dosage ; therapeutic use ; Lung ; diagnostic imaging ; pathology ; Lung Diseases, Interstitial ; diagnosis ; drug therapy ; etiology ; Male ; Methotrexate ; administration & dosage ; therapeutic use ; Muscle Weakness ; diagnosis ; epidemiology ; etiology ; Prognosis ; Respiratory Function Tests ; Retrospective Studies ; Tomography, X-Ray Computed
10.Clinical comparative analysis for pulmonary histoplasmosis and progressive disseminated histoplasmosis.
Yan ZHANG ; Xiaoli SU ; Yuanyuan LI ; Ruoxi HE ; Chengping HU ; Pinhua PAN
Journal of Central South University(Medical Sciences) 2016;41(12):1345-1351
To compare clinical features, diagnosis and therapeutic effect between pulmonary histoplasmosis and progressive disseminated histoplasmosis.
Methods: A retrospective analysis for 12 cases of hospitalized patients with histoplasmosis, who was admitted in Xiangya Hospital, Central South University during the time from February 2009 to October 2015, was carried out. Four cases of pulmonary histoplasmosis and 8 cases of progressive disseminated histoplasmosis were included. The differences of clinical features, imaging tests, means for diagnosis and prognosis were analyzed between the two types of histoplasmosis.
Results: The clinical manifestations of pulmonary histoplasmosis were mild, such as dry cough. However, the main clinical symptoms of progressive disseminated histoplasmosis were severe, including recurrence of high fever, superficial lymph node enlargement over the whole body, hepatosplenomegaly, accompanied by cough, abdominal pain, joint pain, skin changes, etc.Laboratory examination showed pancytopenia, abnormal liver function and abnormal coagulation function. One pulmonary case received the operation of left lower lung lobectomy, 3 cases of pulmonary histoplasmosis and 6 cases of progressive disseminated histoplasmosis patients were given deoxycholate amphotericin B, itraconazole, voriconazole or fluconazole for antifungal therapy. One disseminated case discharged from the hospital without treatment after diagnosis of histoplasmosis, and 1 disseminated case combined with severe pneumonia and active tuberculosis died ultimately.
Conclusion: As a rare fungal infection, histoplasmosis is easily to be misdiagnosed. The diagnostic criteria depends on etiology through bone marrow smear and tissues biopsy. Liposomeal amphotericin B, deoxycholate amphotericin B and itraconazole are recommended to treat infection for histoplasma capsulatum.
Abdominal Pain
;
etiology
;
Amphotericin B
;
therapeutic use
;
Antifungal Agents
;
therapeutic use
;
Biopsy
;
Cough
;
epidemiology
;
Death
;
Deoxycholic Acid
;
therapeutic use
;
Diagnostic Errors
;
Drug Combinations
;
Fever
;
etiology
;
Hepatomegaly
;
etiology
;
Histoplasma
;
Histoplasmosis
;
complications
;
diagnosis
;
mortality
;
therapy
;
Humans
;
Invasive Fungal Infections
;
complications
;
diagnosis
;
therapy
;
Itraconazole
;
therapeutic use
;
Lung
;
microbiology
;
surgery
;
Lung Diseases, Fungal
;
diagnosis
;
surgery
;
therapy
;
Pneumonia
;
complications
;
mortality
;
Recurrence
;
Retrospective Studies
;
Splenomegaly
;
etiology
;
Treatment Outcome
;
Tuberculosis
;
complications
;
mortality